Terms: = Head and neck cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
5 results:
1. Immune Checkpoint Inhibitors Serve as the First-Line Treatment for Advanced head and neck cancer.
Huang Y; Zhou H; Zhao G; Wang M; Luo J; Liu J
Laryngoscope; 2024 Feb; 134(2):749-761. PubMed ID: 37610169
[TBL] [Abstract] [Full Text] [Related]
2. Costs Associated With Imaging Surveillance After Treatment for head and neck cancer.
Nocon CC; Kennedy A; Jaffe J; Pruitt J; Kuchta K; Bhayani MK
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):632-637. PubMed ID: 33983375
[TBL] [Abstract] [Full Text] [Related]
3. Pin1 promoter rs2233678 and rs2233679 polymorphisms in cancer: a meta-analysis.
Zhu YM; Liu JW; Xu Q; Yuan Y
Asian Pac J Cancer Prev; 2013; 14(10):5965-72. PubMed ID: 24289610
[TBL] [Abstract] [Full Text] [Related]
4. TSH-activated signaling pathways in thyroid tumorigenesis.
Rivas M; Santisteban P
Mol Cell Endocrinol; 2003 Dec; 213(1):31-45. PubMed ID: 15062572
[TBL] [Abstract] [Full Text] [Related]
5. Osteoradionecrosis of the mandible after oromandibular cancer surgery.
Celik N; Wei FC; Chen HC; Cheng MH; Huang WC; Tsai FC; Chen YC
Plast Reconstr Surg; 2002 May; 109(6):1875-81. PubMed ID: 11994586
[TBL] [Abstract] [Full Text] [Related]
